Calcitonin precursors: Early markers of gut barrier dysfunction in patients with acute pancreatitis

Pancreas

Volumn 27, Issue 3, 2003, Pages 239-243

  Ammori, Basil J ^a,e   Becker, K L ^c   Kite, P ^b   Snider, R H ^c   Nylen E S ^c   White, J C ^c   Barclay, G R ^d   Larvin, M ^a   McMahon, M J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^e MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Acute pancreatitis; Antiendotoxin antibodies; Calcitonin precursors; Endotoxin; Gut barrier function; Intestinal permeability

Indexed keywords

ANTIBODY; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CALCITONIN; ENDOTOXIN; MACROGOL; PROCALCITONIN;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL TRACT; HOSPITAL ADMISSION; HUMAN; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; ENDOTOXEMIA; ENDOTOXINS; FEMALE; HUMANS; INFLAMMATION; INTESTINES; MALE; MIDDLE AGED; PANCREATITIS; PERMEABILITY; POLYETHYLENE GLYCOLS; PROGNOSIS; PROTEIN PRECURSORS;

EID: 0141483117     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200310000-00008     Document Type: Article

References (35)

1. Gloor B, Muller CA, Worni M, Martignoni ME, Uhl W, Buchler MW. Late mortality in patients with severe acute pancreatitis. Br J Surg. 2001; 88:975-979.
2. Beger HG, Bittner R, Block S, Büchler M. Bacterial contamination of pancreatic necrosis: a prospective clinical study. Gastroenterology. 1986; 91:433-438.
3. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract, The "undrained abscess" of multiple organ failure. Ann Surg. 1993;218:111-119.
4. Swank GM, Deitch EA. Role of the gut in multiple organ failure: Bacterial translocation and permeability changes. World J Surg. 1996;20:411-417.
5. Juvonen PO, Alhava EM, Takala JA. Gut permeability in patients with acute pancreatitis. Scand J Gastroenterol. 2000;35:1314-1318.
6. Ammori BJ, Leeder P, King RFG, et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure and death. J Gastrointest Surg. 1999;3:252-262.
7. Deitch EA, Xu D, Berg RD. Bacterial translocation from the gut impairs systemic immunity. Surgery. 1991;109:269-276.
8. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut. 1992;33:1126-1128.
9. Windsor JA, Fearon KC, Ross JA, et al. Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg. 1993;80:1042-1046.
10. Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Pancreas. 2003;26:122-129.
11. Rahman SH, Ammori BJ, Holmfield J, Larvin M, McMahon MJ. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg. 2003;7:26-36.
12. Snider RH, Nylén ES, Becker KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. Invest Med. 1997;45:552-560.
13. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515-518.
14. Nylén ES, Snider RH, Thompson KA, Rohatgi P, Becker KL. Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci. 1996;312:12-18.
15. Aouifi A, Piriou V, Bastien O, et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med. 2000;28: 3171-3176.
16. Müller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000;28:977-983.
17. Harbarth S, Holeckova K, Froidevaux C, et al. Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164:396-402.
18. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut. 1997;41:832-840.
19. Mandi Y, Farkas G, Takacs T, Boda K, Lonovics J. Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis. Int J Pancreatol. 2000;28:41-49.
20. Ammori BJ, Becker KL, Kite P, et al. Calcitonin precursors in the prediction of severity of acute pancreatitis on the day of admission. Br J Surg. 2003;90:197-204.
21. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79: 1605-1608.
22. Preas HL 2nd, Nylén ES, Snider RH, et al. Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis. 2001;184:373-376.
23. de Werra I, Jaccard C, Corradin SB, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med. 1997;25:607-613.
24. Becker KL, Snider RH Jr, Moore CF, Monoghan KG, Silva OL. Calcitonin in extrathyroidal tissues of man. Acta Endocrinol. (Copenh) 1979;92: 746-751.
25. Becker KL, Monaghan KG, Silva OL. Immunocytochemical localization of calcitonin in Kulchitsky cells of human lung. Arch Pathol Lab Med. 1980;104:196-198.
26. Müller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-1 gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86:396-404.
27. Bradley EL III. A clinically based classification system for acute pancreatitis. Arch Surg. 1993;128:586-590.
28. Menzies IS. Transmucosal passage of inert molecules in health and disease. In: Skadhauge E, Heintze K, eds. Intestinal Absorption and Secretion. Falk Symposium 36. Lancaster: MTP. 1984:527-543.
29. Barclay GR, Scott BB, Wright IH, Rogers PN, Smith DG, Poxton IR. Changes in anti-endotoxin IgG antibody and endotoxaemia in three cases of Gram-negative septic shock. Circ Shock. 1989;29:93-106.
30. Whang KT, Steinwald PM, White JC, et al. Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab. 1998;83: 3296-3301.
31. Morgenthaker NG, Struck J, Fischer-Schulz C, Bergmann A. Sensitive immunoluminometric assay for the detection of procalcitonin. Clin Chem. 2002;48:789-790.
32. Nylén ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med. 1998;26: 1001-1006.
33. Whang KT, Vath SD, Becker KL, et al. Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock. 2000;14:73-78.
34. Wagner KE, Martinez JM, Vath SD, et al. Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs. Crit Care Med. 2002;30:2313-2321.
35. Martinez JM, Wagner KE, Vath SD, et al. Late immunoneutralization of procalcitonin arrests progression of lethal porcine sepsis. Surg Inf 2001; 2:193-203.